Life Science Leader Blogs

  1. Can China Be Trusted?
    10/1/2018

    Rob Wright discusses China’s history of intellectual property (IP) theft, and wonders if the government-sponsored 10-year initiative, Made in China 2025 (MIC 2025), could exacerbate the problem.

  2. The Future Of Biopharma — Netherlands Style
    9/18/2018

    Rob Wright shares what he looks forward to learning about during an upcoming press tour of the Netherlands, beyond the fact that the European Medicines Agency (EMA) will be relocating there in 2019.

  3. What Mylan Could Learn About Accountability
    8/31/2018

    Mylan’s inability to adequately supply its EpiPen during the 2018 back-to-school time is the latest example of corporate leadership lacking accountability.

  4. Are Genetically Modified Organisms (GMO) A Blessing Or A Curse?
    8/27/2018

    A question about GMOs submitted to our editorial board leads us to look more closely into this issue and how it affects the pharma industry.

  5. Why A Biopharma Executive Founded A Game-Changing Conference
    8/20/2018

    Amir Kalali, M.D., former global head of Quintiles (now IQVIA) neuroscience center of excellence, provides insight on why he decided to found an educational conference, The CNS Summit, while still working as a biopharmaceutical industry executive.

  6. Is It Possible For A Biopharmaceutical Executive To Transcend Their Industry?
    8/9/2018

    What current biopharma leaders have the potential to “transcend” beyond this industry? Chief Editor Rob Wright gives his top three choices.

  7. Are You Up To Speed On AI Terminology?
    7/24/2018

    A primer on AI terminology for the upcoming August feature with Sanofi’s Medical Function EVP, Ameet Nathwani, M.D.

  8. The Drug Pricing Dilemma, Pfizer, And President Trump
    7/13/2018

    An op-ed regarding Pfizer’s drug-pricing actions, President Trump, and the potential impact on the biopharmaceutical industry’s image.

  9. At The End Of The Day — And Other Phrases That Could Be Used Less
    7/9/2018

    A review of buzzwords and phrases that should be used less in the world of business.

  10. Did BIO 2018 Do More Than Make History In Boston?
    6/14/2018

    BIO 2018 does more than make business meeting history, but facilitates personal connections that can lead toward doing better business.